E-mail us
Bioavailability Enhancement Formulations

Recent statistics indicate that approximately 70% of small molecules under development belong to Biopharmaceutics Classification System (BCS) II or IV poorly water-soluble drugs.


At Crystal Pharmatech, we utilize advanced amorphous solid dispersion (ASD) technology, including spray drying (SD) and hot melt extrusion (HME) to help our clients to solve the following challenges:



The spray drying process is a particle engineering technique that is a proven approach to improving the solubility of poorly soluble compounds. It has been widely used to enhance bioavailability in drug manufacturing for the following advantages:

Even spray drying is an effective way for solving bioavailability challenges, but it requires strong expertise in process design and development. The core technical team at Crystal Pharmatech has solid knowledge and expertise in the fundamentals and scaling-up principles for spray drying process and commercialized several amorphous solid dispersion solid dosage form drug products. With our deep understanding of all quality and regulatory requirements and world-class manufacturing and analytical equipment, we are confident that we can support amorphous solid dispersion formulation development world widely at high speed and with high quality.


HME is widely recognized as an effective technology that enhances the bioavailability of poorly soluble APIs, ultimately improving patient compliance and making the manufacturing process more efficient.

Crystal Pharmatech's technical team has a solid background in polymer materials, chemical engineering, and mechanical engineering, a deep understanding of the principles of rheology and engineering, and industrial, advanced expertise in hot melt extrusion technology. We have successful experiences developing immediate and controlled release formulations and processes, scaling them up and commercializing them. Like spray drying, we have world-class bench-to-production equipment and analytical instruments for hot melt extrusion. We hope to help innovative drug hunters overcome the challenges on poorly water-soluble drugs with hot melt extrusion technology.

Leave a Message

Related Updates in Crystal Pharmatech

Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303